📖

QRFPR Protein

wiki page Created: 2026-04-02T19:42:30 By: crosslink-v3 Quality: 50% ✓ SciDEX ID: wiki-proteins-qrfp-protein
Linked Artifacts (28)
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying perivascular spaces and g50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying protein aggregation cross50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying perivascular spaces and g50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬Anti-amyloid antibodies (lecanemab, donanemab) have ~0.1% br50%
related🔬RNA binding protein dysregulation across ALS FTD and AD50%
mentions🧪Heat Shock Protein 70 Disaggregase Amplification40%
mentions🧪Serine/Arginine-Rich Protein Kinase Modulation40%
mentions🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto40%
mentions🧪Magnetosonic-Triggered Transferrin Receptor Clustering40%
mentions🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m40%
related🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m40%
related🧪Heat Shock Protein 70 Disaggregase Amplification40%
related🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto40%
related🧪Magnetosonic-Triggered Transferrin Receptor Clustering40%
related🧪Serine/Arginine-Rich Protein Kinase Modulation40%
mentions🔬What are the mechanisms underlying protein aggregation cross32%
mentions🔬What are the mechanisms underlying rna binding protein dysre32%
mentions🔬RNA binding protein dysregulation across ALS FTD and AD32%
mentions🔬Analyze circuit-level changes in neurodegeneration using All32%
mentions🔬Anti-amyloid antibodies (lecanemab, donanemab) have ~0.1% br32%